Clinical Trials Logo

Clinical Trial Summary

This study is being done to test the safety and efficacy of the study drug LY3556050 for the treatment of diabetic peripheral neuropathic pain. This trial is part of the chronic pain master protocol (H0P-MC-CPMP) which is a protocol to accelerate the development of new treatments for chronic pain.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04707157
Study type Interventional
Source Eli Lilly and Company
Contact
Status Terminated
Phase Phase 2
Start date May 6, 2021
Completion date June 13, 2022

See also
  Status Clinical Trial Phase
Completed NCT04094662 - A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain Phase 3
Not yet recruiting NCT06054087 - Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy N/A
Not yet recruiting NCT05292066 - Efficacy of Pregabalin Vs Duloxetine in Diabetic Peripheral Neuropathic Pain at Variable Dose Early Phase 1
Completed NCT04688671 - Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain Phase 2
Recruiting NCT06203002 - A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) Phase 2
Completed NCT05620576 - A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05) Phase 2
Completed NCT04146896 - Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN) Phase 2
Recruiting NCT05521737 - Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy N/A
Terminated NCT02156336 - Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP) Phase 4
Recruiting NCT06122012 - To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China N/A
Recruiting NCT06221241 - Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain Phase 2
Completed NCT01314222 - Diabetic Peripheral Neuropathic Pain (DPNP) Phase 2
Completed NCT00829387 - Cognitive Behavioral Therapy for Diabetic Neuropathic Pain N/A
Not yet recruiting NCT05766969 - Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA Phase 1/Phase 2
Completed NCT05349357 - Slider Versus Tensioner Neural Mobilization in Diabetic Peripheral Neuropathy N/A
Completed NCT03909841 - Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition
Completed NCT04476108 - Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain Phase 2
Not yet recruiting NCT04953221 - The Effect of YJ001 on Diabetic Peripheral Neuropathic Pain.
Completed NCT05177094 - Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain Phase 2
Completed NCT02318706 - DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain Phase 3